| Microscopy imaging of liposomes: from coverslips to environmental SEM S Bibi, R Kaur, M Henriksen-Lacey, SE McNeil, J Wilkhu, E Lattmann, ... International journal of pharmaceutics 417 (1-2), 138-150, 2011 | 163 | 2011 |
| Characterization and optimization of bilosomes for oral vaccine delivery JS Wilkhu, SE McNeil, DE Anderson, Y Perrie Journal of drug targeting 21 (3), 291-299, 2013 | 74 | 2013 |
| The application of monolayer studies in the understanding of liposomal formulations B Moghaddam, MH Ali, J Wilkhu, DJ Kirby, AR Mohammed, Q Zheng, ... International journal of pharmaceutics 417 (1-2), 235-244, 2011 | 71 | 2011 |
| Effect of incorporating cholesterol into DDA: TDB liposomal adjuvants on bilayer properties, biodistribution, and immune responses R Kaur, M Henriksen-Lacey, J Wilkhu, A Devitt, D Christensen, Y Perrie Molecular pharmaceutics 11 (1), 197-207, 2014 | 57 | 2014 |
| Formulation design considerations for oral vaccines J Wilkhu, SE McNeil, DJ Kirby, Y Perrie Therapeutic delivery 2 (9), 1141-1164, 2011 | 42 | 2011 |
| Cannabinoid formulations J Wilkhu, J Bender US Patent App. 15/640,033, 2018 | 38 | 2018 |
| Investigating the role of cholesterol in the formation of non-ionic surfactant based bilayer vesicles: thermal analysis and molecular dynamics JS Wilkhu, D Ouyang, MJ Kirchmeier, DE Anderson, Y Perrie International journal of pharmaceutics 461 (1-2), 331-341, 2014 | 35 | 2014 |
| Development of a solid dosage platform for the oral delivery of bilayer vesicles JS Wilkhu, SE McNeil, DE Anderson, M Kirchmeier, Y Perrie European Journal of Pharmaceutical Sciences 108, 71-77, 2017 | 25 | 2017 |
| Parenteral formulations S Wright, J Wilkhu US Patent 11,229,612, 2022 | 18 | 2022 |
| Oral pharmaceutical formulation comprising cannabinoids and poloxamer J Wilkhu, J Bender US Patent App. 16/959,357, 2021 | 17 | 2021 |
| Oral cannabinoid formulations S Wright, J Wilkhu US Patent 11,426,362, 2022 | 16 | 2022 |
| Pharmaceutical composition comprising a cannabinoid J Wilkhu, J Bender US Patent App. 16/959,350, 2021 | 14 | 2021 |
| Modified release composition comprising a cannabinoid J Wilkhu, J Bender, M Collins US Patent App. 16/959,354, 2021 | 14 | 2021 |
| Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines JS Wilkhu, SE McNeil, DE Anderson, Y Perrie Drug delivery and translational research 4, 233-245, 2014 | 11 | 2014 |
| Methods for preparing vesicles and formulations produced therefrom DE Anderson, Y Perrie, M Kirchmeier, JS Wilkhu US Patent App. 13/979,317, 2013 | 10 | 2013 |
| Non-ionic surfactant technology for the delivery and administration of sub-unit flu antigens J Wilkhu Aston University, 2013 | 7 | 2013 |
| pH dependent release coated microparticle cannabinoid formulations J Wilkhu, A Silcock US Patent 11,160,757, 2021 | 5 | 2021 |
| Parenteral formulations S Wright, J Wilkhu US Patent App. 17/548,232, 2022 | 3 | 2022 |
| Cannabinoid formulations A Silcock, J Wilkhu US Patent App. 17/615,422, 2022 | 2 | 2022 |
| Developing Bilayer-Based Delivery Systems for Oral Delivery of Subunit Vaccines JS Wilkhu, Y Perrie Subunit Vaccine Delivery, 95-123, 2015 | 2 | 2015 |
Yvonne PerrieProfessor in Drug DeliveryVerified email at strath.ac.uk
